Best fit Maximum weight-loss potential Outcome signal Up to 22.5% mean loss Evidence cue SURMOUNT evidence Decision rhythm Week 1 / Weeks 4-8 / Months 3-6 Best-fit signals Choose Compounded Tirzepatide when these match your goal Maximum weight-loss potential Decision timeline What to expect as you compare Compounded Tirzepatide Timelines vary by goal, dose, baseline health, and consistency
J., Alarcn De La Lastra, C., Motilva, V., & La Casa, C
Press the space key then arrow keys to make a selection
Peptide Therapy: Enhancing Weight Loss from Within Peptides are short chains of amino acids that serve as building blocks for proteins in the body
* Mucus discharge
Abstract Pathogenic variants in one allele of the KAT6A gene encoding the histone acetyltransferase KAT6A (MOZ, MYST3) cause ArboledaTham syndrome (ARTHS), characterised by developmental delay, cognitive impairment, and autism-like behaviours